Related Experiment Video

Updated: Apr 7, 2026

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

1.3K

Recognition and management of children with protracted bacterial bronchitis

Siba P Paul1, Swathi Sanapala2, Jayesh M Bhatt3

  • 1Specialty Trainee Year 8 in Paediatrics, Bristol Royal Hospital for Children, Bristol BS2 8BJ.

British Journal of Hospital Medicine (London, England : 2005)
|July 4, 2015
PubMed

Insights

Protracted bacterial bronchitis is a clinical diagnosis that causes persistent moist cough in children. This condition leads to disturbed sleep, exercise intolerance, and significant illness, managed with minimal tests and long antibiotic treatments.

Area of Science:

  • Pediatrics
  • Respiratory Medicine
  • Infectious Diseases

Background:

  • Chronic moist cough in children can indicate serious underlying health issues.
  • Protracted bacterial bronchitis (PBB) is a common cause of persistent wet cough in pediatric patients.
  • PBB significantly impacts a child's quality of life, affecting sleep and physical activity.

Purpose of the Study:

  • To define the clinical characteristics and diagnostic approach for protracted bacterial bronchitis in children.
  • To outline current management strategies for PBB, emphasizing antibiotic therapy.

Main Methods:

  • This is a clinical diagnosis based on characteristic symptoms.
  • Diagnostic evaluation typically involves minimal investigations.
  • Treatment focuses on prolonged courses of appropriate antibiotics.

Main Results:

  • Protracted bacterial bronchitis is characterized by persistent moist cough lasting over 4 weeks.
  • Associated symptoms include sleep disturbance and reduced exercise tolerance.
  • The condition is associated with considerable morbidity in affected children.

Conclusions:

  • Protracted bacterial bronchitis is a treatable cause of chronic moist cough in children.
  • Prompt diagnosis and prolonged antibiotic treatment are key to successful management.
  • Further research may elucidate optimal diagnostic criteria and treatment durations.

More Related Videos

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.7K
Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

24.2K

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
897
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.2K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.3K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
626
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
5.0K